LBRX today
$43.77-$0.94 (-2.10%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourBearish
15 minDescending Triangle
5 minConsolidating
Daily trend turns up above $50.16
Key levels
Resistance$50.16
Resistance$46.34
Support$41.24
Support$38.24
Latest news & SEC filings
EarningsLB Pharmaceuticals posts third-quarter 2026 financial results
All LBRX news →About LB Pharmaceuticals
LB Pharmaceuticals is a drug developer focused on therapies for psychiatric and neurological conditions. Its main experimental medicine, LB-102, is being tested in later-phase human studies for schizophrenia and bipolar depression, with additional work planned for depression that has not responded to standard treatment. The company is also working on an injectable, longer-lasting version of LB-102. It is based in the United States and holds worldwide rights to its lead program.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
LB PHARMACEUTICALS INC (LBRX)
What Is the Price Target for LBRX?
SEPT Low Target
$35.00
SEPT Mid Target
$60.00
SEPT High Target
$80.00
Analyst Consensus
$60.00
Is LBRX a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LBRX.
Start Free Trial →Is LBRX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$60.00
12
Moat Score
NONE
3/9
Piotroski Score
17.3
Altman Z-Score
What Is Smart Money Doing with LBRX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LBRX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
98.22%
FCF Growth YoY
34.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for LBRX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LBRX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:15 | $44.71 | 1,033 | $$46K | BUY |
| 20:37:34 | $44.86 | 1,192 | $$53K | SELL |
| 20:33:32 | $44.65 | 1,600 | $$71K | BUY |
| 18:42:23 | $44.61 | 2,400 | $$107K | BUY |
| 18:32:06 | $44.64 | 1,300 | $$58K | SELL |
5 dark pool trades shown · $$336K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for LB PHARMACEUTICALS INC (LBRX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LBRX — frequently asked questions
What is LBRX stock price today?
LB PHARMACEUTICALS INC (LBRX) is at $43.77, down 2.10% (-$0.94) at the Nov 12, 2026 close.
Why is LBRX stock moving today?
Latest LBRX news — Nov 5, 2026: LB Pharmaceuticals posts third-quarter 2026 financial results
Why did LBRX stock move on Oct 9, 2026?
LB Pharmaceuticals shares closed at $37.22, up 1.76% on the day, after Canaccord Genuity initiated coverage with a Buy rating and a $65 price target. The stock traded in a wide range between $35.69 and $38.50 on volume of 638,065 shares.
What is the LBRX price target?
The average analyst price target for LBRX is $60.00, ranging from $35 to $80, based on 9 analysts. Latest: LB Pharmaceuticals upgrade on Oct 9, 2026.
What do analysts rate LBRX?
Analyst ratings for LBRX: 0 Buy, 11 Hold, 1 Sell — consensus Hold.
Did LBRX beat earnings?
LBRX last reported on Aug 11, 2026: EPS -$1.71 vs -$0.80 expected — a miss of 112.8%.
What is LBRX's P/E ratio?
LBRX trades at a P/E of 1.8 vs a Healthcare average of 18.5.
Does LBRX pay a dividend?
LBRX does not currently pay a dividend.
What are LBRX support and resistance levels?
Support: $41.24, $38.24, $33.88. Resistance: $46.34, $50.16.
What are insiders doing with LBRX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on LBRX?
Nov 5, 2026: LB Pharmaceuticals posts third-quarter 2026 financial results